Abstract
Advances continue to be made in the field of pediatric oncology ever since treatment for childhood cancer began in 1948. Since then, there has been exponential progress in the care for children with cancer as reflected in the current survival rates, which approach 90%. With such incredible survival rates, the number of childhood cancer survivors has increased significantly, with present estimates being above 300,000 in the United States alone. This success has, however, not been without cost. Long-term studies of cancer survivors have brought to light specific adverse effects of therapy, which often present years after treatment is finished, termed “late effects.” Over the years, it has become apparent that monitoring for and treating these late effects of treatment is essential for the continuing health of young cancer survivors. It is now well recognized that childhood cancer survivors require long-term follow-up care given by an integrated team of qualified and invested specialty-care providers in collaboration with their primary caregivers. These teams deliver care using a risk-based approach, following a systematic plan for lifelong screening, surveillance, and prevention that incorporates risks based on the previous cancer, cancer therapy, genetic predispositions, lifestyle behaviors, and co-morbid health conditions.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Hewitt M, Weiner SL, Simone JV. Childhood Cancer survivorship: improving care and quality of life. Washington DC: National Academics Press; 2003.
Shad A, Gossai N. Late effects of childhood cancer and treatment. Emedicine. 2010; Dec 9. Available at http://emedicine.medscape.com/article/990815.
Hennessy K, Arastu N, Shad A. ‘The Next Step: Crossing the Bridge to Survivorship’. Washington DC: Lombardi Comprehensive Cancer Center; 2008.
Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Eng J Med. 2006;355:1572–82.
Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111(12):5515–23.
Zeltzer LK, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2396–404.
Aziz N, Oeffinger K, Brooks S, Turoff A. Comprehensive long-term follow-up programs for pediatric cancer survivors. Cancer. 2006;107:841–8.
Oeffinger KC, Eshelman DA, Tomlinson GE, Buchanan GR. Programs for adult survivors of childhood cancer. J Clin Oncol. 1998;16:2864–7.
Tercyak KP, Donze JR, Prahlad S, Mosher RB, Shad AT. Multiple behavioral risk factors among adolescent survivors of childhood cancer in the Survivor Health and Resilience Education (SHARE) Program. Ped Blood Cancer. 2006;47(6):825–30.
Mays D, Black JD, Mosher RB, Heinly A, Shad AT, Tercyak KP. Efficacy of the Survivor Health and Resilience Education (SHARE) program to improve bone health behaviors among adolescent survivors of childhood cancer. Am Behav Med. 2011 Feb 17.
Lipshultz SE, Colan SO, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324(12):808–15.
Berry GJ, Jorden M. Pathology of radiation and anthracycline cardiotoxicity. Pediatr Blood Cancer. 2005;44(7):630–7.
Krischer JP, Epstein S, Cuthbertson DO, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997;15(4):1544–52.
Oeffinger KC. Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease? Pediatr Blood Cancer. 2008;50(2 Suppl):462–7. discussion 468.
Ginsberg JP, Hobbie WL, Ogle SK, et al. Prevalence of and risk factors for hydrocele in survivors of Wilms tumor. Pediatr Blood Cancer. 2004;42(4):361–3.
Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res. 1989;25(6):561–7.
Bonato C, Severino RF, Elnecave RH. Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radiotherapy. J Pediatr Endocrinol Metab. 2008;21(10):943–9.
Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med. 1991;325(9):599–605.
Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA. 1988;259(14):2123–5.
Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol. 1999;33(1):24–8.
De Bruin ML, Van Dulmen-den Broeder E, Van den Berg MH, Lambalk CB. Fertility in female childhood cancer survivors. Endocr Dev. 2009;15:135–58.
Green OM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677–85.
Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oneal. 1999;33(1):29–33.
•• Anderson FS, Kunin-Batson AS. Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatr Blood Cancer. 2009;52(2):159–64. Young cancer survivors are at risk for chemotherapy-associated neurocognitive late effects (problems with thinking and reasoning). This paper provides a comprehensive literature review of these late effects caused by chemotherapy alone and discusses the neural mechanisms involved.
Costa J. Neurocognitive effects of childhood cancer treatment. In: Raffa R, Tallirada R, editors. Chemo fog: cancer chemotherapy-related cognitive impairment. New York: Lands Bioscience and Springer Science; 2010.
Haddy TB, Mosher RB, Reaman GH. Late effects in long-term survivors after treatment for childhood acute leukemia. Clin Pediatr. Mar 4, 2009.
Stuber M, et al. Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics. 2010;125(5):1124–34.
Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin’s disease. N Engl J Med. 1996;334(12):745–51.
Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oneal. 2003;21(23):4386–94.
Zebrack BJ, Zeltzer LK, Whitton J, Mertens AC, Odom L, Berkow R. Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin’s disease, and non-Hodgkin’s lymphoma: a report from the Childhood Cancer Survivor Study. Pediatrics. 2002;110(1 Pt 1):42–52.
Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs. 2008;24:208–17.
Freyer D. Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches. J Clin Oncol. 2010;28:4810–8.
Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin. 2004;54(4):208–36.
Wolff JA. History of pediatric oncology. Pediatr Hematol Oncol. 1991;8(2):89–91.
Nissen MJ, et al. Views of primary care providers on follow-up care of cancer patients. Fam Med. 2007;39:477–82.
Snyder CF, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998–2002. J Clin Oncol. 2009;27:1054–61.
Nathan P, Greenberg M, et al. Medical care on long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26:4401–9.
•• Nathan P, Ford J, et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study Cohort. J Clin Oncol. 2009;27:2663–73. Childhood cancer survivors are at risk for medical and psychosocial effects of cancer and its related therapy. This manuscript summarizes publications from the Childhood Cancer Survivor Study (CCSS) that have examined health behaviors, risk-based health care, and interventions to promote healthy lifestyle practices. Long-term survivors use tobacco and alcohol and have inactive lifestyles at higher rates than is ideal given their increased risk of cardiac, pulmonary, and metabolic late effects. Few survivors get regular care.
•• Nathan P, Hayes-Lattine B, Sisler J, Hudson M. Critical issues in transition and survivorship for adolescents and young adults with cancer. Cancer. 2011;117:2335–41. Cancer survivors need transitional services throughout life, which include health-related education, health surveillance and screening, management of cancer-related complications, and psychosocial support relevant to their developmental needs. The availability of resources for survivors varies by geography, health care system, and survivor characteristics. Adolescents and young adults who receive their care outside of a pediatric cancer center have particularly limited access. This manuscript addresses the limitations in cancer center resources (along with survivor preference) and strongly suggests that the long-term care of survivors needs to be shared between the cancer centers and primary care providers in survivors’ communities.
Hall S, Samuel L, Murchie P. Toward shared care for people with cancer: developing the model with patients and GPs. Fam Pract. 2011;28:1–11.
Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol. 2006;24:5117–24.
Ostbye T, Yarnell KSH, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic disease in primary care? Ann Fam Med. 2005;33:209–14.
Hong S, Nekhlyudov L, et al. Cancer survivorship care: exploring the role of the general internist. J Gen Intern Med. 2009;24 Suppl 2:495–500.
Smith SM, Allwright S, O’Dowd T. Effectiveness of shared care across the interface between primary and specialty care in chronic disease management. Cochrane Database Syst Rev (3):CD004910.
Blaauwbrock R, Zwart N, et al. The willingness of general practitioners to be involved in the follow-up of adult survivors of childhood cancer. J Cancer Surviv. 2007;1:292–7.
Rihani R, Bazzeh F, Faqih N, Sultan I. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry. Cancer. 2010;116(18):4385–94.
Termuhlen AM, Tersak JM, Liu Q, Yasui Y, Stovall M, Weathers R, Deutsch M, Sklar CA, Oeffinger KC, Armstrong G, Robison LL, Green DM. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011;57(7):1210–6. doi:10.1002/pbc.23090. Epub 2011 Mar 7.
Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083–95. Epub 2010 Jul 15.
Acknowledgment
Hyundai Hope on Wheels Scholar Grant, which continues to support Late Effects Research in the Cancer Survivorship Program at Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shad, A., Myers, S.N. & Hennessy, K. Late Effects in Cancer Survivors: “The Shared Care Model”. Curr Oncol Rep 14, 182–190 (2012). https://doi.org/10.1007/s11912-012-0224-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11912-012-0224-1